NCT03322189View on ClinicalTrials.gov

Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

March 22, 2020

Study Completion Date

April 1, 2020

Conditions
Pharmacogenomic
Interventions
GENETIC

pharmacogenomic

Standard Operating Procedures on Pharmacogenomic testing and changes made to specific SOP

Trial Locations (1)

33558

DCABM, Land O' Lakes

Sponsors

Collaborators (1)

PAS Research Services
All Listed Sponsors
collaborator

PAS Research Services

OTHER

lead

Data Collection Analysis Business Management

OTHER